InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: EichKing post# 8751

Thursday, 11/30/2017 7:05:18 PM

Thursday, November 30, 2017 7:05:18 PM

Post# of 44784
Hey EichKing. One thing to remember. I know Filgastrim used 100% male NHP's for one of their trials, and a high percentage for their others. I seem to recall a high percentage of males for Entolomid as well. We were 100% successful treating males, as female biological differences make them more succeptible to ARS. Amd rumours of government purchase of Entolimod have been going on for a long time with nada so far.

But competition for any of our products should never be overlooked.